Osmitrol 20 g/100mL

Osmitrol 20 g/100mL is a mannitol injection solution used for osmotic diuresis and reducing intracranial pressure. This intravenous medication is manufactured by Baxter Healthcare Company in the USA.

Osmitrol 20 g/100mL is primarily used to promote diuresis, which helps the kidneys remove excess fluids and waste. It is also used to reduce intracranial pressure and treat conditions related to fluid retention. Mannitol injections are often considered when other treatments are not suitable.

Common effects of Osmitrol 20 g/100mL may include increased urine output and potential dehydration if not properly managed. Some individuals may experience headaches, nausea, or dizziness. Always follow medical guidance when using this medication.

Osmitrol 20 g/100mL should be handled with care, ensuring proper storage and administration. It is important to monitor fluid balance and electrolyte levels during treatment. Individuals with certain medical conditions, such as heart or kidney problems, should use this medication under medical supervision.

Mannitol may interact with other medications, including diuretics and certain blood pressure drugs. It is important to inform healthcare providers about all medications being taken to avoid potential interactions. Alcohol and other substances may also affect the efficacy of Osmitol.